Sixth flu vaccine approved
Executive Summary
Accelerated approval of CSL Limited's Afluria for protection against flu virus types A and B in adults marks sixth seasonal influenza vaccine approved by FDA, agency says Sept. 28. CDC estimates a record 132 million vaccine doses will be available for 2007-2008 season (1"The Pink Sheet" Aug. 27, 2007, In Brief)...
You may also be interested in...
Final FDA flu vaccine guidances
FDA issues final guidances to outline the regulatory pathways for development and approval of seasonal and pandemic influenza vaccines May 31. Both guidances recommend use of novel adjuvants and cell culture and recombinant manufacturing technologies. Guidelines also allow use of surrogate endpoints such as immune response to support accelerated approval (1"The Pink Sheet" March 13, 2006, p. 26)...
US FDA And NIST Form Partnership To Boost Advanced Manufacturing Techniques
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic Looks To Adaptive DBS To Advance Treatment Of Parkinson’s Disease
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: